Centerbridge Partners’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-100,000
Closed -$980K 56
2021
Q4
$980K Hold
100,000
0.06% 23
2021
Q3
$973K Hold
100,000
0.11% 23
2021
Q2
$968K Hold
100,000
0.09% 26
2021
Q1
$965K Buy
+100,000
New +$968K 0.09% 32

Other funds holding SHAC

Centerbridge Partners's SHAC Position: Q1 2022 in Review

Centerbridge Partners sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q1 2022, closing a stake of 100,000 shares — an estimated $980K sold.

Centerbridge Partners first reported a position in SHAC in Q1 2021 and held it in 4 quarters. The position peaked at $980K in Q4 2021. 68 funds tracked by Wall St. Rank hold SHAC as of Q1 2022.

  • Centerbridge Partners reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Centerbridge Partners sold 100,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q1 2022, an estimated $980K.
  • Centerbridge Partners first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 4 quarters.
  • Centerbridge Partners's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $980K in Q4 2021.
  • 68 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q1 2022.

Based on Centerbridge Partners's 13F filing for Q1 2022, filed 16 May 2022.